Expect Spravato to Be Saved for Hard-to-Treat Depression

May 2019

You'll hear buzz about Spravato (sprah-VAH-toh, esketamine), a new Rx nasal spray to treat resistant depression in adults.

Spravato is a cousin to ketamine...called "Special K" on the street.

So it's not surprising that Spravato is a C-III due to risks of misuse and abuse...and that it can cause sedation, hallucinations, increased blood pressure, and other side effects.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Certification Watch for Changes to Pharmacy Tech Certification and Credentialing
Ophthalmology Be Ready to Dispense Cequa, A New Rx Eye Drop for Dry Eyes
ADHD Listen for Questions About Psychosis With ADHD Stimulants
Parkinson's Disease Inbrija Will Be an Inhaled "On Demand" Med for Parkinson's Disease
Aspirin An Aspirin a Day May Not Always Keep the Doctor Away
Communication Up Your Communication Game With "SBAR"
Dermatology Avoid Common Errors With Meds for Skin Lesions Caused by the Sun
Beta-Blockers Take Notice of COPD or Asthma Patients Getting a Beta-Blocker
Depression Expect Spravato to Be Saved for Hard-to-Treat Depression
Laws & Regulations Be Vigilant With Rxs Written by a Prescriber for Themselves or Family

Expect Spravato to Be Saved for Hard-to-Treat Depression

Practical advice for a better career, with unlimited access to CE

Table of Contents